As of January, California is the first state in the country to partner with a nonprofit to develop, produce and sell its own ...

California is the first state in the country to partner with a nonprofit to develop, produce and sell its own insulin.

The new year will begin with some first-of-their-kind laws in several states. Hawaii will become the first state to raise its ...

SACRAMENTO, CA – Setting a national precedent, California will sell its own state-branded insulin, making life-saving diabetes medication affordable for millions. Governor Gavin Newsom announced that ...

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...

Metformin vs Insulin in Pregnancy: Trials Continue 'The wires constantly cross in my mind about whether we’re balancing efficacy and risk in a meaningful way.' Medscape Medical News, December 16, 2025 ...

California’s health care landscape today would probably disappoint the Gavin Newsom who spent much of 2017 and 2018 campaigning to become governor.

Generic drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with the reference product – namely Sanofi's ...

Sanofi’s Toujeo – a follow-up to its long-acting insulin drug Lantus – has underperformed commercially since launch but the company hopes new data could help it gather momentum. The French drugmaker ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...